Eligo Bioscience
USPTO PatentsView assignee record - 36 granted patents across 10 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Eligo ranks #8,790 of 49,997 tracked US assignees by granted-patent volume, with 36 patents across 10 technology areas.
- #8,790
- of 49,997 US assignees by volume
- Top 9%
- by Innovation Score (53.5/100)
- 16.4
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R8790 · Foreign Corporation #8,790 · 36 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-SMALL 36 grants
- UPPER-Q #8,790/49,997
- PHOTO-FINISH E2interactive
- CPC-FOCUS C12N · 10 areas
- INNOV-PAR 53.5/100
- CLAIMS-RICH 16.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: E2interactive, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Eligo’s 53.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Eligo
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Eligo Bioscience · this assignee
Eligo Bioscience · this assignee
54 score
- Embecta · near
Embecta · near
54 score
- GD Midea Heating &… · near
GD Midea Heating &… · near
54 score
- NextNav · near
NextNav · near
54 score
- Osram Sylvania · near
Osram Sylvania · near
54 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Eligo's Innovation Score is 53.5/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Eligo?
Each dot is one of Eligo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Eligo’s own 16.4 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Eligo's grants concentrate
Eligo Bioscience is a focused PatentsView assignee: 10 CPC subclasses with 86.1% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2023 (13 grants) versus a trough of 1 in 2020. By volume, Eligo sits between E2interactive, Inc. and Fortune Gold Enterprises Ltd..
Eligo's three-year grant acceleration
Eligo Bioscience shows 29 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Eligo's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- E2interactive
E2interactive, Inc.
36 patents
- Encell Technology
Encell Technology, Inc.
36 patents
- Echelon
Echelon Corporation
36 patents
- Ecole Nationale S…
Ecole Nationale Supérieure de Chimie de Montpellier
36 patents
- Embecta
Embecta Corp.
36 patents
- Emissive Energy
Emissive Energy Corp.
36 patents
- Fastbrick IP PTY
Fastbrick IP PTY Ltd
36 patents
- Fortune Gold Ente…
Fortune Gold Enterprises Ltd.
36 patents
- Eligo Bioscience ◀
Eligo Bioscience
36 patents
What this shows Eligo holds 36 patents at rank #8,791, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Eligo
By rank, the assignees closest to #8,791 in granted patent volume.
- E2interactive, Inc. #8,787 · 36 patents
- Encell Technology, Inc. #8,788 · 36 patents
- Echelon Corporation #8,789 · 36 patents
- Ecole Nationale Supérieure de Chimie de Montpellier #8,790 · 36 patents
- Embecta Corp. #8,792 · 36 patents
- Emissive Energy Corp. #8,793 · 36 patents
- Fastbrick IP PTY Ltd #8,794 · 36 patents
- Fortune Gold Enterprises Ltd. #8,795 · 36 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Eligo's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Eligo, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Eligo ranks #357 of 4,144 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (54 here).
Eligo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 9% higher than 91% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 2.8% |
| 2021 | 3 | 8.3% |
| 2022 | 8 | 22.2% |
| 2023 | 13 | 36.1% |
| 2024 | 8 | 22.2% |
| 2025partial year | 3 | 8.3% |
Which technologies does Eligo Bioscience patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Eligo Bioscience's patent record in context - here's where to go next.
- Eligo Bioscience's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 86.1% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #8,790 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Eligo Bioscience against E2interactive, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 53.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.